KRAS and pancreatic neoplasm: Notably, the most frequently observed mutations in PDAC involve the Kirsten rat sarcoma viral oncogene homolog gene (KRAS); the G12D and G12V mutations occur in approximately 90% of cases and are specific to pancreatic cancer.